Fine Foods & Pharmaceuticals N.T.M的远期盈利收益率是5.5%. 查看Fine Foods & Pharmaceuticals N.T.M. S.p.A.的远期盈利收益率趋势、图表等
Fine Foods & Pharmaceuticals NTM的未调整ebit于декабрь 2022触及5年低点,是-9.17百万。 Fine Foods & Pharmaceuticals NTM的未调整ebit于2019 (621.549千, -93.9%)、2021 (-3.95百万, -123.1%)和2022 (-9.17百万, +132.2%)减少和于2020 (17.129百万, +2,655.8%)和2023 (2.511百万, -127.4%)增加。
packaging thermosensitive pharmaceuticals and foods, suchascheeseoryogurt, thus adding to WACKER’s extensive portfolio [...] wacker.com wacker.com 产品由于聚合物链醋酸乙烯含量高, 所以也能够在较低的温度下胶合, 这使VINNOL® H 30/48 M成了奶酪、酸奶等热敏食品或药品的理想包装材料, ...
Fine chemicals that are physiologically active, such as pharmaceuticals, cosmetics, nutritional supplements, flavoring agents as well as additives for foods, feed, and fertilizer are produced by enzymatically or through microbial fermentation. The identification of enzymes that catalyze the target reaction ...
Oncogen Pharma Dr. Vijayavitthal T. Mathad, M. Sc, Ph. D Sr. VP MSN Laboratories Dr. Kamlesh Padiya Associate Director, Process Research and Development, NDDD Lupin Pharmaceuticals Sponsor PerkinElmer Register Free: https://www.chromatographyonline.com/lcgc_w/global_chemicalRelated...
Fine Foods & Pharmaceuticals NTM的预期ebitda增长率是101.9%. 查看Fine Foods & Pharmaceuticals NTM SpA的预期EBITDA增长率趋势、图表等
Fine Foods & Pharmaceuticals NTM下一财年的预估资本支出的一致预期中值是16.8百万。 接下来 5 个财年,Fine Foods & Pharmaceuticals NTM的预估资本支出的一致预期中值均值是 18.68百万。
Fine Foods & Pharmaceuticals NTM的价格 / 最近12个月的自由现金流于Desember 2021触及5年低点,是-78.0x。 Fine Foods & Pharmaceuticals NTM的价格 / 最近12个月的自由现金流于2021 (-78.0x, -201.9%)和2023 (-33.0x, +172.2%)减少和于2020 (76.5x, -233.8%)和2022 (-12.1x, -84.5%)增加。
3D printing is considered a versatile approach, suitable for achieving pharmaceuticals from polymeric matrices of well-defined porosity, geometry, and size for controlled-release dosage forms [208,209,210]. According to the high number of published papers (for example: [1,2,3,4,5,6,7,8,14,...